Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
970 hedge funds and large institutions have $45.4B invested in Allergan plc in 2019 Q2 according to their latest regulatory filings, with 156 funds opening new positions, 275 increasing their positions, 415 reducing their positions, and 161 closing their positions.
115% more funds holding in top 10
Funds holding in top 10: 27 → 58 (+31)
16% more capital invested
Capital invested by funds: $39B → $45.4B (+$6.39B)
3% less first-time investments, than exits
New positions opened: 156 | Existing positions closed: 161
2% less funds holding
Funds holding: 991 → 970 (-21)
12% less call options, than puts
Call options by funds: $1.24B | Put options by funds: $1.4B
34% less repeat investments, than reductions
Existing positions increased: 275 | Existing positions reduced: 415
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$763M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$492M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$406M |
| 4 |
Millennium Management
New York
|
+$238M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$211M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$520M |
| 2 |
VAM
Veritas Asset Management
London,
United Kingdom
|
-$377M |
| 3 |
KSCM
King Street Capital Management
New York
|
-$277M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$257M |
| 5 |
AL
Appaloosa LP
Short Hills,
New Jersey
|
-$255M |
AGN Hedge Fund Activity: Q2 2019 in Review
970 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2019, worth a combined $45.4B — up 16% from $39B a quarter earlier.
Sellers outnumbered buyers: 161 funds closed out of AGN and 156 opened new positions — a net loss of 5 holders — while 415 trimmed existing stakes and 275 added.
The largest buyer was UBS Group, adding an estimated $763M. The largest seller was Janus Henderson Group, cutting an estimated $520M.
- 970 institutional investors held Allergan plc (AGN) as of Q2 2019, down from 991 in Q1 2019.
- Funds reported $45.4B of Allergan plc stock for Q2 2019, up 16% quarter-over-quarter.
- 156 funds opened new Allergan plc positions in Q2 2019 and 161 closed out, a net change of -5 holders.
- The largest Allergan plc buyer in Q2 2019 was UBS Group, an estimated $763M added.
- The largest Allergan plc seller in Q2 2019 was Janus Henderson Group, an estimated $520M sold.
Based on aggregated 13F filings for Q2 2019.